Cited by 191Extracellular vesicles in diseaseCellular transport and secretionNanoparticle-Based Drug Delivery

Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics

Open access
Rodrigues, Meryl, Fan, Jia, Lyon, Christopher, Wan, Meihua, Hu, Ye·2018·Theranostics

Abstract

Extracellular vesicles (EVs), or exosomes, are nanovesicles of endocytic origin that carry host and pathogen-derived protein, nucleic acid, and lipid cargos. They are secreted by most cell types and play important roles in normal cell-to-cell communications but can also spread pathogen- and host-derived molecules during infections to alter immune responses and pathophysiological processes. New research is beginning to decipher how EVs influence viral and bacterial pathogenesis. In this review, we will describe how EVs influence viral and bacterial pathogenesis by spreading pathogen-derived factors and how they can promote and inhibit the immune response to these pathogens. We will also discuss the emerging potential of EVs as diagnostic and therapeutic tools.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/thno.20576

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many viruses such as HIV, coxsackievirus, hepatitis B and C, influenza, Epstein-Barr virus, and SARS-CoV-2 hijack cellular and mitochondrial programs to enhance viral replication, package virus into EVs, and use EVs containing virus or viral components to subvert the immune response to obtain a replicative advantage in the host.

    “Many viruses such as HIV, coxsackievirus, hepatitis B and C, influenza, Epstein-Barr virus, and SARS-CoV-2 highjack cellular and mitochondrial programs to enhance viral replication, package virus into EVs, and use EVs containing virus or viral components to subvert the immune response to obtain a replicative advantage in the host (Figure 1).”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [47]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Cardiomyocytes and pericytes express ACE2 and TMPRSS2, as well as other accessory proteins needed for viral infection by SARS-CoV-2.

    “Thus, cardiomyocytes and pericytes express ACE2 and TMPRSS2, as well as other accessory proteins (ie, NRP1 [neuropilin-1 receptor], CD147 , integrin α 5 β 1, and cathepsin B/L) needed for viral infection by SARS-CoV-2”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [27]

    The Viruses section discusses extracellular vesicles transferring receptors involved in HIV infection and affecting hepatitis-virus infection. Searches of our copy for cardiomyocytes, pericytes, ACE2, TMPRSS2, SARS-CoV-2, and the named accessory proteins found no passage addressing their expression or role in SARS-CoV-2 infection. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • An engineered heart tissue model of COVID-19 found that SARS-CoV-2 infection of heart tissue led to contractile issues, sarcomere disassembly, TNFα cytokine production, macrophage infiltration, and cell death, mimicking viral myocarditis.

    “An engineered heart tissue model of COVID-19 found that SARS-CoV-2 infection of the heart tissue led to contractile issues, sarcomere disassembly, TNF α cytokine production, macrophage infiltration, and cell death, mimicking viral myocarditis. 27”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [27]

    The Viruses section discusses extracellular vesicles in infections such as HIV and hepatitis, while the Bacteria section describes TNFα production and macrophage recruitment in mycobacterial infections. Searches for SARS-CoV-2, engineered heart tissue, sarcomere disassembly, and viral myocarditis found no passage addressing the claimed model or its outcomes. No page numbers were provided for these sections. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [48]Feng ZD Hensley L McKnight KL Hu FY Madden V Ping LF A pathogenic picornavirus acquires an envelope by hijacking cellular membranes Nature 2013 496 367 -+ 23542590 PMC3631468
  2. [52]Pileri P Uematsu Y Campagnoli S Galli G Falugi F Petracca R Binding of hepatitis C virus to CD81 Science 1998 282 938 41 9794763
  3. [68]Lenassi M Cagney G Liao MF Vaupotic T Bartholomeeusen K Cheng YF HIV Nef is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4(+) T Cells Traffic 2010 11 110 22 19912576 PMC2796297
  4. [110]Qazi KR Gehrmann U Domange Jordo E Karlsson MC Gabrielsson S Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism Blood 2009 113 2673 83 19176319

Cited by

Sorted by citations

Authors
Rodrigues, M., Fan, J., Lyon, C., Wan, M., & Hu, Y.
Affiliations
  • Arizona State University (US)
  • West China Medical Center of Sichuan University (CN)
Corresponding author
  • Wan, Meihua
  • Hu, Ye
Venue
Theranostics
Published
2018
Volume
8
Issue
10
Pages
2709-2721
ISSN
1838-7640 (ISSN-L)
OpenAlex
W2802105343
Cited by
191
References
112
Citations by year
2026: 17 · 2025: 19 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 38 · 2020: 36 · 2019: 17 · 2018: 2
FWCI
2.28
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Theranostics (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (R01AI113725, R21AI126361, R01AI122932)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD090927)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
extracellular vesicles, exosomes, viral infection, bacterial infection, pathogenesis, immunomodulation, pathogen dispersal, cell-to-cell communication, diagnostics, therapeutics
MeSH terms
Extracellular Vesicles, Theranostic Nanomedicine, Animals, Bacterial Infections, Humans, Virus Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review